تحميل...
Strategies to Inhibit Myc and Their Clinical Applicability
Myc is an oncogene deregulated in most—perhaps all—human cancers. Each Myc family member, c-, L-, and N-Myc, has been connected to tumor progression and maintenance. Myc is recognized as a “most wanted” target for cancer therapy, but has for many years been considered undruggable, mainly due to its...
محفوظ في:
| الحاوية / القاعدة: | Front Cell Dev Biol |
|---|---|
| المؤلفون الرئيسيون: | , , |
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
Frontiers Media S.A.
2017
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5322154/ https://ncbi.nlm.nih.gov/pubmed/28280720 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fcell.2017.00010 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|